Document is current

Article History

Received: 14 August 2021

Accepted: 8 February 2022

First Online: 26 February 2022

Declarations

:

: This study was approved by both the Institutional Review Board at Pitzer College and HealthRIGHT 360’s IRB committee, project number: 2020-32R1. Pitzer College’s institutional review board’s review was carried out in accordance with the requirements of Part 46, “Protection of Human Subjects” of Title 45 of the Code of Federal Regulations and the “US Department of Health and Human Services (DHHS) Federal-Wide Assurance (FWA) for the Protection of Human Subjects for Domestic (US) Institutions,” Pitzer College Assurance #FWA00001138.

: This manuscript contains no identifying information.

: The authors declare that they have no competing interests. Dr. TK is the chief medical officer of Prototypes and Mr. JK is the clinical director of Prototypes.